Novel Compounds
Proprietary Pipeline
Family: Various
Our novel compound programme represents Phyto-Medichem's proprietary discovery pipeline — a portfolio of emerging botanical actives under investigation for unique pharmacological properties. These compounds are identified through our systematic ethnobotanical screening platform and advanced bioassay-guided fractionation workflows.
Traditional Use
Candidates in this programme are identified from traditional medicine systems across multiple cultures and geographies. Our ethnobotanical research team documents and validates traditional use claims as a starting point for modern pharmacological investigation, working in partnership with indigenous knowledge holders.
Active Compounds
Mechanisms of Action
- Neuroprotective pathway modulation
- Novel receptor interactions
- Proprietary mechanisms under investigation
- Multi-target pharmacology
Applications
Clinical Status
Our lead novel candidate NOV-801 is in early discovery, with additional candidates at various stages of screening and characterisation. Detailed data is available under NDA for qualified partners.
Regulatory Notes
Regulatory pathways are being evaluated on a compound-by-compound basis. Our regulatory affairs team engages early with relevant authorities to define the optimal approval strategy for each candidate.
Sourcing & Sustainability
Source materials are obtained through a combination of ethical wild-harvesting partnerships, cultivated sources, and controlled cultivation programmes, depending on the botanical species and conservation status.
Interested in This Compound?
Contact our team to discuss licensing opportunities, custom development, or research partnerships.
Contact Our Team